 |
|
Bongkyun Park, Kyuhyung Jo, Tae Gu Lee, Ik Soo Lee, Jin Sook Kim, Chan-Sik Kim
J Exerc Nutrition Biochem. 2019;23(4):14-22. Published online 2019 Dec 31 DOI: https://doi.org/10.20463/jenb.2019.0026
|
|
Citations to this article as recorded by
 Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation
Zhuoyu Hu, Xiangdong Chen, Qi Hu, Menglong Zou, Zhimin Liu
Pharmacology Research & Perspectives.2025;[Epub] CrossRef Puerarin alleviates hyperosmotic stress-induced oxidative stress, inflammation, apoptosis and barrier damage of human corneal epithelial cells by targeting SIRT1/NLRP3 signaling
Yue Dong, Yin-Yin Ding, Wei-Ping Gao
Toxicology in Vitro.2024; 94: 105722. CrossRef Network pharmacology and molecular docking to explore Polygoni Cuspidati Rhizoma et Radix treatment for acute lung injury
Jia-Lin Zheng, Xiao Wang, Zhe Song, Peng Zhou, Gui-Ju Zhang, Juan-Juan Diao, Cheng-En Han, Guang-Yuan Jia, Xu Zhou, Bao-Qing Zhang
World Journal of Clinical Cases.2023; 11(19): 4579. CrossRef Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
Hsiao-Hsuan Wang, Wei-Yu Chen, Yi-Hsun Huang, Sheng-Min Hsu, Yeou-Ping Tsao, Yu-Hsiang Hsu, Ming-Shi Chang
Journal of Biomedical Science.2022;[Epub] CrossRef Animal models of dry eye disease: Useful, varied and evolving (Review)
Wei Huang, Konstantinos Tourmouzis, Henry Perry, Robert Honkanen, Basil Rigas
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef Natural PTP1B Inhibitors From Polygonum cuspidatum and Their 2-NBDG Uptake Stimulation
Hong-Luyen Le, Dao-Cuong To, Manh-Hung Tran, Thi-Thuy Do, Phi-Hung Nguyen
Natural Product Communications.2020;[Epub] CrossRef
|